From January 1, 2024 to March 31, 2024, the company has repurchased 680,000 shares, representing 0.17% for CNY 20.95 million. With this, the company has completed the repurchase of 1,597,266 shares, representing 0.41% for CNY 57.46 million under the buyback announced on August 30, 2023.
Shandong Weigao Orthopaedic Device Co., Ltd
Equities
688161
CNE1000050W9
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.59 CNY | -1.45% | +4.03% | -35.85% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.85% | 1.49B | |
+73.43% | 12.41B | |
-19.24% | 8.14B | |
+4.83% | 7.2B | |
+3.66% | 5.93B | |
+11.89% | 5.43B | |
+37.45% | 4.89B | |
-19.82% | 4.09B | |
-35.60% | 2.49B | |
+0.74% | 2.04B |
- Stock Market
- Equities
- 688161 Stock
- News Shandong Weigao Orthopaedic Device Co., Ltd
- Tranche Update on Shandong Weigao Orthopaedic Device Co., Ltd's Equity Buyback Plan announced on August 30, 2023.